You are viewing the site in preview mode
Skip to main content
|
Age
|
Histological results
|
|---|
|
Total
|
Normal (n, %)
|
LSIL (n, %)
|
HSIL (n,%)
|
CA (n,%)
|
CA:OR (95% CI)
|
HSIL+ (n,%)
|
HSIL+:OR (95% CI)
|
|---|
|
≤ 30
|
654
|
253 (38.69%)
|
136 (20.80%)
|
261 (39.91%)
|
4 (0.61%)
|
1.00
|
265 (40.52%)
|
2.465 (1.875–3.241)
|
|
31–40
|
1258
|
500 (39.75%)
|
259 (20.59%)
|
487 (38.71%)
|
12 (0.95%)
|
1.565 (0.503–4.872)
|
499 (39.67%)
|
2.379 (1.850–3.060)
|
|
41–50
|
1011
|
464 (45.90%)
|
201 (19.77%)
|
332 (32.84%)
|
14 (1.38%)
|
2.282 (0.748–6.936)
|
346 (34.22%)
|
1.883 (1.452–2.441)
|
|
51–60
|
448
|
240 (53.57%)
|
110 (24.55%)
|
85 (18.97%)
|
12 (2.68%)
|
4.472 (1.433–13.957)
|
97 (21.65%)
|
1.00
|
|
> 60
|
88
|
48 (54.55%)
|
15 (17.05%)
|
23 (26.14%)
|
3 (3.41%)
|
5.735 (1.262–26.064)
|
26 (29.55%)
|
1.517 (0.911–2.527)
|
|
N
|
3459
|
1505 (43.51%)
|
721 (20.84%)
|
1188 (34.35%)
|
45 (1.30%)
|
–
|
1233 (35.65%)
|
–
|
- ASC-US, atypical squamous cells of undetermined significance; HPV, human papillomavirus; hr-HPV, high-risk human papillomavirus; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; CA, cervical cancer; HSIL+, high-grade squamous intraepithelial lesion and cervical cancer; OR, odds ratio; CI, confidence interval
